ReviewBiomedicines2021

Novel Treatment Strategy Using Second-Generation Androgen Receptor Inhibitors for Non-Metastatic Castration-Resistant Prostate Cancer.

Doo Yong Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.